Fish & Aquatic
Tayyebeh Asadi; Saeid Meshkini; Nasrollah Ahmadifard
Volume 14, Issue 7 , July 2023, , Pages 359-365
Abstract
The role of immunostimulants in reducing diseases and enhancing fish performance has been proven in various studies. In this study, the effects of antioxidant procyanidin and commercial probiotic Bio-Aqua® on some hematological and immune indices of rainbow trout (Oncorhynchus mykiss) were investigated. ...
Read More
The role of immunostimulants in reducing diseases and enhancing fish performance has been proven in various studies. In this study, the effects of antioxidant procyanidin and commercial probiotic Bio-Aqua® on some hematological and immune indices of rainbow trout (Oncorhynchus mykiss) were investigated. A total number of 525 fingerlings in seven treatments (each treatment in triplicates) with experimental diets, including (1) commercial food without supplements (CTL), (2) 400 mg procyanidin kg-1 feed (PC400) , (3) 800 mg procyanidin kg feed-1 (PC800), (4) 0.50% probiotic diet (PB0.5), (5) 1.00% probiotic diet (PB1), (6) probiotic and procianidin 0.50% and 800 mg kg-1 feed, respectively (PB0.5 + PC800) and (7) probiotic and procianidin 1.00% and 400 mg kg-1 feed, respectively, (PB1 + PC400) were fed for eight weeks. The results showed that the use of procyanidin alone did not have any significant effect on blood biochemistry and immune indices. However, the individual use of Bio-Aqua® probiotic could affect the hematological and immune indices of fish, except for monocyte, compared to the control and procyanidin treatments. However, the combined use of the supplements improved the hematological and immune indices of fish. It was concluded that the simultaneous dietary administration of procyanidin and probiotic Bio-Aqua® could improve the general health of rainbow trout.
Mostafa Abdollahi; Samad Lotfollahzadeh; Mohammad Hossein Nazem Shirazi; Sara Shokrpoor; Farhad Moosakhani; Minoo Partovi Nasr
Volume 14, Issue 2 , February 2023, , Pages 109-112
Abstract
Mycoplasma capricolum subspecies capripneumoniae (Mccp) is the etiological agent of caprine contagious pleuropneumonia (CCPP) disease. The CCPP is one of the most severe diseases of goats. A herd of 2,000 goats located in the countryside of Tehran city, Iran, was examined for the study in August 2021. ...
Read More
Mycoplasma capricolum subspecies capripneumoniae (Mccp) is the etiological agent of caprine contagious pleuropneumonia (CCPP) disease. The CCPP is one of the most severe diseases of goats. A herd of 2,000 goats located in the countryside of Tehran city, Iran, was examined for the study in August 2021. In history taking, observation, inspection and clinical examination, high case fatality rate (46.00%) due to respiratory distress and high morbidity of pleuropneumonia (15.00%) syndrome were recorded. Accordingly, ten carcasses of goats were dissected. The epidemiological pattern of the disease, clinical examination findings and the signs of necropsy of dead patients were suspected to CCPP. Four lung samples of necropsied goats were sent to the laboratory for PCR test and in all of them, Mccp was detected and CCPP was also confirmed. The disease was controlled by two measures: (a) the whole herd was first treated with antibiotics (florfenicol and tylosin) and (b) then the Pulmovac-In vaccine was then administered. This study is the first documented report of CCPP occurrence caused by Mccp in Iran and shows the importance of availability of effective vaccines to control and prevention of CCPP.
Tuğçe Demirlek; Ahmet Sabuncu; Sinem Özlem Enginler; Baran Çelik; Ömür Koçak
Volume 12, Issue 4 , December 2021, , Pages 421-427
Abstract
Mastitis is the most important disease in dairy cattle industry because of its high economic losses both in herd management, milk and milk products. The aim of this study was to determine the efficacy of inactivated Parapoxvirus ovis (IPPVO) Para immune activator as a prophylaxis against mastitis and ...
Read More
Mastitis is the most important disease in dairy cattle industry because of its high economic losses both in herd management, milk and milk products. The aim of this study was to determine the efficacy of inactivated Parapoxvirus ovis (IPPVO) Para immune activator as a prophylaxis against mastitis and as the therapy for subclinical mastitis in dairy cattle. The prophylactic effects of IPPVO were investigated in California mastitis test (CMT). Healthy Holstein cows were divided into A1 (n = 30) and A2 (n = 30) subgroups. In addition, 90 subclinical mastitis Holstein cows were divided into subgroups of B1, B2, and B3 to investigate the efficacy of IPPVO treatment. A significant difference in CMT levels was observed (p ˂ 0.01) 30 day after treatment in A groups. The difference in somatic cell count (SCC) levels between the A groups 15, 30 day after treatment was significant (p ˂ 0.01). The results of the CMT among the B groups showed no statistically significant difference (p > 0.05). The results of the SCC tests showed no statistically significant difference (p > 0.05) among the B groups on days 0, 9 and 15 after treatment. Coagulase-negative Staphylococcus (n = 53) and Escherichia coli (n = 30) were the most prevalent bacteria isolated in this study. In conclusion, IPPVO, although had no additional effect when used in combination with antibiotics could possibly be used instead of antibiotics and to protect cattle from subclinical mastitis, however, it is not known how long this prophylaxis effect could last.
